Page last updated: 2024-08-23

paclitaxel and AIDS-Related Opportunistic Infections

paclitaxel has been researched along with AIDS-Related Opportunistic Infections in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (30.77)18.2507
2000's1 (7.69)29.6817
2010's5 (38.46)24.3611
2020's3 (23.08)2.80

Authors

AuthorsStudies
Borok, MZ; Burger, H; Busakhala, NW; Campbell, TB; Caruso, SR; Godfrey, C; Hoagland, B; Hosseinipour, MC; Kosgei, J; Krown, SE; MacPhail, P; Matining, RM; Mngqibisa, R; Moser, CB; Mwelase, N; Nokta, M; Nyirenda, M; Okuku, FM; Oliver, VO; Samaneka, W1
Bacha, JM; Campbell, LR; El-Mallawany, NK; Mehta, PS; Slone, JS; Wilkinson, JP1
Bilgehan Sahin, A; Cubukcu, E; Deligonul, A; Evrensel, T; Ocak, B; Orhan, B; Oyucu Orhan, S1
Asche, C; Biskupiak, J; Goodman, M; Raimundo, K; Silverstein, S1
Bower, M; Robey, RC1
Cianfrocca, M; Dezube, BJ; Krown, SE; Lee, S; Rudek, MA; Sparano, JA; Von Roenn, J1
Sisneros, SC1
Ajisawa, A; Hosoda, T; Imamura, A; Kato, H; Sasaki, S; Suganuma, A; Yanagisawa, N1
Aversa, SM; Cattelan, AM; Trevenzoli, M1
Arbuck, SG1
Howard, W; Scadden, DT; Schwartz, JD1
di Gennaro, G; Juzbasic, S; Nasti, G; Tirelli, U; Vaccher, E1

Reviews

3 review(s) available for paclitaxel and AIDS-Related Opportunistic Infections

ArticleYear
Recommendations for treating life-threatening Kaposi sarcoma during pregnancy in HIV-positive women in low income countries.
    International journal of STD & AIDS, 2020, Volume: 31, Issue:8

    Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antineoplastic Agents; Antiretroviral Therapy, Highly Active; Bleomycin; Doxorubicin; Drug Therapy, Combination; Female; HIV Infections; Humans; Paclitaxel; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Complications, Neoplastic; Sarcoma, Kaposi; Treatment Outcome; Vincristine

2020
Facing up to the ongoing challenge of Kaposi's sarcoma.
    Current opinion in infectious diseases, 2015, Volume: 28, Issue:1

    Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antineoplastic Agents, Phytogenic; Developed Countries; Developing Countries; Doxorubicin; Drug Therapy, Combination; Evidence-Based Medicine; Health Care Rationing; Herpesvirus 8, Human; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Incidence; Paclitaxel; Polyethylene Glycols; Sarcoma, Kaposi

2015
Recent advances in the treatment of AIDS-related Kaposi's sarcoma.
    American journal of clinical dermatology, 2002, Volume: 3, Issue:7

    Topics: AIDS-Related Opportunistic Infections; Angiogenesis Inhibitors; Antineoplastic Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; Humans; Interferons; Paclitaxel; Sarcoma, Kaposi; Tretinoin

2002

Trials

2 trial(s) available for paclitaxel and AIDS-Related Opportunistic Infections

ArticleYear
Treatment of advanced AIDS-associated Kaposi sarcoma in resource-limited settings: a three-arm, open-label, randomised, non-inferiority trial.
    Lancet (London, England), 2020, 04-11, Volume: 395, Issue:10231

    Topics: Adult; Africa; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Bleomycin; Developing Countries; Drug Therapy, Combination; Etoposide; Female; Humans; Male; Paclitaxel; Progression-Free Survival; Sarcoma, Kaposi; Vincristine

2020
Pilot study evaluating the interaction between paclitaxel and protease inhibitors in patients with human immunodeficiency virus-associated Kaposi's sarcoma: an Eastern Cooperative Oncology Group (ECOG) and AIDS Malignancy Consortium (AMC) trial.
    Cancer chemotherapy and pharmacology, 2011, Volume: 68, Issue:4

    Topics: Adult; AIDS-Related Opportunistic Infections; Antineoplastic Agents, Phytogenic; Area Under Curve; Disease-Free Survival; Drug Interactions; Female; HIV Infections; HIV Protease Inhibitors; Humans; Male; Middle Aged; Paclitaxel; Pilot Projects; Sarcoma, Kaposi

2011

Other Studies

8 other study(ies) available for paclitaxel and AIDS-Related Opportunistic Infections

ArticleYear
Efficacy of chemotherapeutics in classic and non-classic Kaposi sarcoma: A single-center retrospective real-world data.
    Bosnian journal of basic medical sciences, 2021, Dec-01, Volume: 21, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; AIDS-Related Opportunistic Infections; Antineoplastic Agents; Doxorubicin; Female; Humans; Male; Middle Aged; Paclitaxel; Polyethylene Glycols; Retrospective Studies; Sarcoma, Kaposi; Survival Rate; Turkey

2021
Cost effectiveness of liposomal doxorubicin vs. paclitaxel for the treatment of advanced AIDS-Kaposi's sarcoma.
    Journal of medical economics, 2013, Volume: 16, Issue:5

    Topics: AIDS-Related Opportunistic Infections; Antineoplastic Agents; Clinical Trials, Phase III as Topic; Cost-Benefit Analysis; Decision Trees; Doxorubicin; Humans; Liposomes; Paclitaxel; Sarcoma, Kaposi

2013
Recalcitrant giant molluscum contagiosum in a patient with advanced HIV disease - eradication of disease with paclitaxel.
    Topics in HIV medicine : a publication of the International AIDS Society, USA, 2010, Volume: 18, Issue:5

    Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; CD4 Lymphocyte Count; HIV Infections; Humans; Injections, Intravenous; Male; Molluscum Contagiosum; Paclitaxel; Tubulin Modulators

2010
[Refractory AIDS-associated Kaposi's sarcoma treated successfully with paclitaxel: a case report].
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 2012, Volume: 86, Issue:3

    Topics: AIDS-Related Opportunistic Infections; Antineoplastic Agents, Phytogenic; Doxorubicin; Humans; Male; Middle Aged; Paclitaxel; Polyethylene Glycols; Sarcoma, Kaposi

2012
Paclitaxel: current developmental approaches of the National Cancer Institute.
    Seminars in oncology, 1995, Volume: 22, Issue:6 Suppl 15

    Topics: AIDS-Related Opportunistic Infections; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Drug Administration Schedule; Endometrial Neoplasms; Esophageal Neoplasms; Female; Germinoma; Head and Neck Neoplasms; Humans; Lung Neoplasms; National Institutes of Health (U.S.); Ovarian Neoplasms; Paclitaxel; Sarcoma, Kaposi; United States; Urinary Bladder Neoplasms

1995
Potential interaction of antiretroviral therapy with paclitaxel in patients with AIDS-related Kaposi's sarcoma.
    AIDS (London, England), 1999, Feb-04, Volume: 13, Issue:2

    Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antineoplastic Agents, Phytogenic; Delavirdine; Drug Interactions; Female; HIV Protease Inhibitors; Humans; Male; Paclitaxel; Reverse Transcriptase Inhibitors; Saquinavir; Sarcoma, Kaposi

1999
HAART is effective as anti-Kaposi's sarcoma therapy only after remission has been induced by chemotherapy.
    Journal of acquired immune deficiency syndromes (1999), 1999, Dec-01, Volume: 22, Issue:4

    Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Humans; Male; Paclitaxel; Reverse Transcriptase Inhibitors; Sarcoma, Kaposi; Vinblastine; Vinorelbine

1999
Paclitaxel for treating KS.
    Project Inform perspective, 1997, Issue:23

    Topics: AIDS-Related Opportunistic Infections; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Daunorubicin; Doxorubicin; Drug Carriers; Humans; Liposomes; Paclitaxel; Sarcoma, Kaposi

1997